Literature DB >> 27959678

Biologic and Clinical Perspectives on Thyroid Cancer.

Somayyeh Fahiminiya1, Leanne de Kock2, William D Foulkes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959678     DOI： 10.1056/NEJMc1613118

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.

Authors:  Shaohua Zhan; Jinming Li; Tianxiao Wang; Wei Ge
Journal:  Oncologist       Date:  2018-05-08

2.  Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.

Authors:  Ling-Chuan Guo; Wei-Dong Zhu; Xiang-Yuan Ma; Hao Ni; En-Jian Zhong; Yang W Shao; Jie Yu; Dong-Mei Gu; Shun-Dong Ji; Hao-Dong Xu; Cheng Ji; Jin-Ming Yang; Yi Zhang
Journal:  Cancer Biol Ther       Date:  2018-09-25       Impact factor: 4.742

3.  Prognosis of a rare subtype of thyroid cancer: Spindle cell thyroid carcinoma.

Authors:  Zeming Liu; Qiuyang Zhao; Wen Zeng; Shuntao Wang; Yiquan Xiong; Hui Guo; Tao Huang; Hongtao Cheng; Liang Guo
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

4.  Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.

Authors:  Juan Tan; Ling Liu; Zhihua Zuo; Bin Song; Tingting Cai; Dafa Ding; Yibing Lu; Xiaolong Ye
Journal:  Oncol Rep       Date:  2020-08-03       Impact factor: 3.906

5.  Mixed medullary-papillary thyroid carcinoma with mixed lymph node metastases: A case report.

Authors:  Vanessa Guerreiro; Cláudia Costa; Joana Oliveira; Ana Paula Santos; Mónica Farinha; Manuel Jácome; Paula Freitas; Davide Carvalho; Isabel Torres
Journal:  Clin Case Rep       Date:  2021-05-24

6.  DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.

Authors:  Rongxin Sun; Longyan Yang; Yan Wang; Yuanyuan Zhang; Jing Ke; Dong Zhao
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

7.  Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer.

Authors:  Tao Tang; Jingtai Zhi; Wei Zhang; Linfei Hu; Xianhui Ruan; Xiaoyu Chen; Zhaohui Wang; Xiangqian Zheng; Ming Gao
Journal:  J Healthc Eng       Date:  2022-02-08       Impact factor: 2.682

8.  Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.

Authors:  Tingyue Qi; Xin Rong; Qingling Feng; Hongguang Sun; Haiyan Cao; Yan Yang; Hao Feng; Linhai Zhu; Lei Wang; Qiu Du
Journal:  Int J Med Sci       Date:  2021-04-26       Impact factor: 3.738

9.  Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer.

Authors:  Hyeok Jun Yun; Minki Kim; Sang Yong Kim; Sungsoon Fang; Yonjung Kim; Hang-Seok Chang; Ho-Jin Chang; Ki Cheong Park
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 5.923

Review 10.  Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis.

Authors:  Ho-Ryun Won; Eonju Jeon; Jae Won Chang; Yea Eun Kang; Kunho Song; Sun Wook Kim; Dong Mee Lim; Tae Kwun Ha; Ki-Wook Chung; Hyo-Jeong Kim; Young Joo Park; Bon Seok Koo
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.